RegulyzeArjuna
Terminalia arjuna · Bark
Arjuna (Terminalia arjuna) is a botanical permitted for use in nutraceuticals and health supplements under India's FSSAI framework, with a permitted limit of 1-5 g; Extract: 0.5-1 g. Regulyze tracks its regulatory status, limits and label requirements across regulatory frameworks.
Regulatory status
| Framework | Status | Limit | Source | Last reviewed |
|---|---|---|---|---|
| India — FSSAI | Permitted | 1-5 g; Extract: 0.5-1 g | FSS (Health Supplements, Nutraceuticals…) Regulations 2022 | 2026-06-20 |
Coverage for the USA (FDA), EU (EFSA), UK, GCC and ASEAN is being added — this page updates automatically as frameworks are assessed.
About Arjuna
Arjuna is tracked in the Regulyze Ingredient Intelligence database as a botanical (Terminalia arjuna). It is listed in India's FSSAI schedules under the regulatory name Arjun / Parth. The regulatory details on this page are generated from Regulyze's structured regulatory dataset and are reviewed against the cited source.
Frequently asked questions
Is Arjuna permitted in nutraceuticals under FSSAI (India)?
Arjuna (Terminalia arjuna) (listed in the regulation as “Arjun / Parth”) is currently permitted for use in health supplements and nutraceuticals under India's FSSAI framework, per FSS (Health Supplements, Nutraceuticals…) Regulations 2022. Always verify against the current official regulation for your product and market.
What is the permitted dosage of Arjuna?
The permitted level recorded for Arjuna is 1-5 g; Extract: 0.5-1 g. Limits can vary by product type and market — confirm against the current regulation.
What product category does Arjuna belong to?
Arjuna is classified under: Botanicals.
What is the botanical (scientific) name of Arjuna?
Arjuna corresponds to Terminalia arjuna, with the bark used in nutraceutical preparations.
Source: FSS (Health Supplements, Nutraceuticals…) Regulations 2022 · Last reviewed: 2026-06-20 · Data version: db-2026-06-20. Indicative only — verify against the current official regulation before use.